{"slug":"tb-500-glp1-muscle-loss","head_index":23,"current":{"title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","updated_at":"2026-07-17T02:42:15.203Z"},"revisions":[{"n":0,"ts":"2026-06-29 08:29:51","title":"TB-500 for GLP-1 Muscle Loss","status":"published","bytes":1019,"hash":"6b0f5a6185ded47f02597dd04ef48e40d9e24d5ac410f91d7f601e24bafbfe22"},{"n":1,"ts":"2026-06-29T08:41:04.697Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":1947,"hash":"816ba70317c6562afc46c9d3f850587bfd0b03997e91586f9e1f0b9507c75bfe"},{"n":2,"ts":"2026-06-29T10:07:08.025Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":1947,"hash":"3ca392f9ec26546e25084282c5441042767650550f08407105a55b6efdc43248"},{"n":3,"ts":"2026-06-29 12:00:15","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":2000,"hash":"97f8ea188d1a297ea74c2bf6b41c59ae0ae0bfb4d393fe47a3130af9cbee7306"},{"n":4,"ts":"2026-06-29T12:47:36.098Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":2000,"hash":"3cd11939a2cb1951939b1be192f67c9c5741a3e621f35e93f9631e7172a00772"},{"n":5,"ts":"2026-06-29T12:47:36.641Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":2000,"hash":"5e2ae08fbbc84991f8463a392313ab796237deef53d93c7979c405ea0de02af1"},{"n":6,"ts":"2026-06-29T12:47:36.672Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":2000,"hash":"e3cd092f845a30cae1590f747d93ed11088b597a98e19657b95c634626d4e3a6"},{"n":7,"ts":"2026-06-29T12:47:36.702Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":2000,"hash":"c923cfa947015bb01beb86953f2055ce34e492f7881968f0deee34f1c8d7b004"},{"n":8,"ts":"2026-06-29T12:47:36.739Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":2000,"hash":"49dc1abe27c017fc9cb40eea9db35b0672c66e4d52aaf3f4099a388e615e1683"},{"n":9,"ts":"2026-06-29T12:47:37.403Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":2000,"hash":"a25f67972a29814806d50e2c7149e7928b50ee5b1d9b18b173630685dbd64250"},{"n":10,"ts":"2026-06-29T12:51:00.698Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":2000,"hash":"b2f37b11cde099597b7fab5d3dae06f1438ded113bbf11f1fcc3ff8b26883a9d"},{"n":11,"ts":"2026-06-29T12:51:02.566Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":2000,"hash":"b52d66a40189fd1e8e46a14898ab6bc44a91f329182391c64c01400f2600938b"},{"n":12,"ts":"2026-06-29T12:55:07.845Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":2000,"hash":"88fed437230bb9ea2c6af3383531b49bb6a9d957ca4e1d287c58f971d3544c12"},{"n":13,"ts":"2026-06-29T12:56:12.555Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":2000,"hash":"b64d44e46060b84c7cc274fcd7b029233887ffbd42c1ba8ea26b6cb7ba319144"},{"n":14,"ts":"2026-06-29T13:21:59.321Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":2000,"hash":"2dc456da8dd40e6c507b7d67e5be83ff28dffc9f8b3cfceb8c739b3de8e59e5e"},{"n":15,"ts":"2026-06-29T14:06:17.774Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":2000,"hash":"acf178b46be7589d58db3cfee97defedb785a7a121696cf094eefc83798ca03c"},{"n":16,"ts":"2026-06-29T14:20:56.075Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":2000,"hash":"c06f1ec4b93d4b4dba7ad3d9ef39fdd8aa74c50d9a72a20515b41277433cb3d4"},{"n":17,"ts":"2026-06-29T16:48:06.800Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":5004,"hash":"56d56bc8bd578882965a580ac0b6d679a53a518da782900ec5e0397243474f22"},{"n":18,"ts":"2026-06-29T17:20:36.750Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":5004,"hash":"5461774be2290a108f24f0f0ea8a1f93535b44a9f6c0423732db75873f61c78c"},{"n":19,"ts":"2026-06-29T17:29:22.568Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":5004,"hash":"777b1b63d4b33799daeb2771c497e01c64931afbf0ee3c1567bba143b046cc6b"},{"n":20,"ts":"2026-06-29T19:14:02.871Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":5004,"hash":"bf2e4195a528d97f68c0ea249f7bd763c8cbe8e7901a9a1fe63406ae2d544ae1"},{"n":21,"ts":"2026-06-29T19:23:04.058Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":5004,"hash":"dc0a54ea0970bdb8c07c87ead5ad6efbbb8a13adf5b93a6f81a91ab7520d462a"},{"n":22,"ts":"2026-06-29T20:28:05.462Z","title":"TB-500 and GLP-1 Agonist-Associated Lean Mass Changes: Evidence Mapping","status":"published","bytes":5004,"hash":"244fb0915e025386e330b4d36c738345eb8cb6261a4855aba5db27c66af223c6"}]}